Paul Thurk is a Managing Director with ARCH Venture Partners.
Mr. Thurk joined ARCH in 2000 from SSM Ventures, via a two-year Kauffman Fellowship with the Partnership. He focuses on solid-state lighting, semiconductors, advanced materials, nanotechnology, electronics and optoelectronics. Mr. Thurk has also been a key part of ARCH’s efforts at Los Alamos National Laboratory and at Sandia National Laboratories in their entrepreneur-in-residence program with the U.S. Department of Energy. He recently established ARCH’s Dublin, Ireland office to assess European-sourced technology and investment opportunities.
Mr. Thurk was co-founder and initial CEO of Innovalight (acquired by DuPont-DD) and CoolEdge Lighting. He has participated in the development of ARCH portfolio companies Kotura (acquired by Mellanox), Nitronex (acquired by MACOM), Cambrios, and Semprius. He co-founded Carrick Therapeutics and Genomics Medicine Ireland, and serves as a Director of both companies, and is a board observer to Movidius, inc in Dublin.
Formerly, Mr. Thurk was a Director of Operations for NABS, a supplier of electronics components where he established operations on behalf of NABS in five countries and was responsible for setting-up business infrastructure, systems, personnel, and processes in each. In addition, he developed and launched several innovative supply chain management programs.
Mr. Thurk holds a B.S. in Economics from the Wharton School of the University of Pennsylvania and an M.B.A. from the University of Texas at Austin.